ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/08/22 | 1,960 | 2,015 | 1,938 | 1,965 | -20 | -1% | 163,000 |
| 2013/08/21 | 1,951 | 2,033 | 1,950 | 1,985 | +20 | +1% | 231,000 |
| 2013/08/20 | 2,060 | 2,099 | 1,920 | 1,965 | -80 | -3.9% | 405,000 |
| 2013/08/19 | 1,892 | 2,072 | 1,872 | 2,045 | +191 | +10.3% | 517,000 |
| 2013/08/16 | 1,801 | 1,935 | 1,773 | 1,854 | +137 | +8% | 352,000 |
| 2013/08/15 | 1,654 | 1,740 | 1,650 | 1,717 | +63 | +3.8% | 96,000 |
| 2013/08/14 | 1,636 | 1,656 | 1,635 | 1,654 | +35 | +2.2% | 65,000 |
| 2013/08/13 | 1,596 | 1,620 | 1,588 | 1,619 | +26 | +1.6% | 64,000 |
| 2013/08/12 | 1,576 | 1,598 | 1,572 | 1,593 | +3 | +0.2% | 22,000 |
| 2013/08/09 | 1,577 | 1,590 | 1,576 | 1,590 | +13 | +0.8% | 56,000 |
| 2013/08/08 | 1,550 | 1,590 | 1,550 | 1,577 | +38 | +2.5% | 103,000 |
| 2013/08/07 | 1,540 | 1,540 | 1,522 | 1,539 | -4 | -0.3% | 20,000 |
| 2013/08/06 | 1,526 | 1,547 | 1,520 | 1,543 | +17 | +1.1% | 32,000 |
| 2013/08/05 | 1,510 | 1,526 | 1,507 | 1,526 | +2 | +0.1% | 12,000 |
| 2013/08/02 | 1,520 | 1,524 | 1,510 | 1,524 | -3 | -0.2% | 26,000 |
| 2013/08/01 | 1,505 | 1,530 | 1,505 | 1,527 | +25 | +1.7% | 28,000 |
| 2013/07/31 | 1,509 | 1,510 | 1,502 | 1,502 | -6 | -0.4% | 12,000 |
| 2013/07/30 | 1,502 | 1,532 | 1,500 | 1,508 | +6 | +0.4% | 22,000 |
| 2013/07/29 | 1,527 | 1,530 | 1,501 | 1,502 | -26 | -1.7% | 18,000 |
| 2013/07/26 | 1,555 | 1,555 | 1,525 | 1,528 | -27 | -1.7% | 32,000 |
| 2013/07/25 | 1,566 | 1,566 | 1,541 | 1,555 | +15 | +1% | 37,000 |
| 2013/07/24 | 1,540 | 1,540 | 1,535 | 1,540 | -10 | -0.6% | 13,000 |
| 2013/07/23 | 1,532 | 1,550 | 1,532 | 1,550 | +5 | +0.3% | 23,000 |
| 2013/07/22 | 1,531 | 1,545 | 1,530 | 1,545 | +17 | +1.1% | 20,000 |
| 2013/07/19 | 1,551 | 1,553 | 1,525 | 1,528 | -25 | -1.6% | 16,000 |
| 2013/07/18 | 1,523 | 1,554 | 1,517 | 1,553 | +41 | +2.7% | 58,000 |
| 2013/07/17 | 1,515 | 1,519 | 1,503 | 1,512 | +7 | +0.5% | 19,000 |
| 2013/07/16 | 1,523 | 1,523 | 1,505 | 1,505 | -6 | -0.4% | 19,000 |
| 2013/07/12 | 1,515 | 1,516 | 1,506 | 1,511 | -5 | -0.3% | 22,000 |
| 2013/07/11 | 1,518 | 1,518 | 1,510 | 1,516 | ±0 | ±0% | 16,000 |
| 2013/07/10 | 1,522 | 1,523 | 1,506 | 1,516 | -2 | -0.1% | 25,000 |
| 2013/07/09 | 1,520 | 1,520 | 1,500 | 1,518 | +11 | +0.7% | 26,000 |
| 2013/07/08 | 1,518 | 1,520 | 1,505 | 1,507 | -9 | -0.6% | 23,000 |
| 2013/07/05 | 1,519 | 1,519 | 1,493 | 1,516 | -3 | -0.2% | 18,000 |
| 2013/07/04 | 1,514 | 1,520 | 1,510 | 1,519 | +5 | +0.3% | 17,000 |
| 2013/07/03 | 1,500 | 1,516 | 1,500 | 1,514 | +21 | +1.4% | 16,000 |
| 2013/07/02 | 1,507 | 1,507 | 1,470 | 1,493 | +6 | +0.4% | 27,000 |
| 2013/07/01 | 1,518 | 1,520 | 1,470 | 1,487 | -18 | -1.2% | 24,000 |
| 2013/06/28 | 1,491 | 1,508 | 1,482 | 1,505 | +44 | +3% | 40,000 |
| 2013/06/27 | 1,460 | 1,461 | 1,430 | 1,461 | +2 | +0.1% | 13,000 |
| 2013/06/26 | 1,480 | 1,480 | 1,458 | 1,459 | +2 | +0.1% | 8,000 |
| 2013/06/25 | 1,462 | 1,470 | 1,443 | 1,457 | -5 | -0.3% | 14,000 |
| 2013/06/24 | 1,474 | 1,474 | 1,462 | 1,462 | -14 | -0.9% | 10,000 |
| 2013/06/21 | 1,394 | 1,480 | 1,364 | 1,476 | +84 | +6% | 54,000 |
| 2013/06/20 | 1,396 | 1,396 | 1,380 | 1,392 | +2 | +0.1% | 14,000 |
| 2013/06/19 | 1,387 | 1,390 | 1,367 | 1,390 | +4 | +0.3% | 7,000 |
| 2013/06/18 | 1,392 | 1,392 | 1,363 | 1,386 | +9 | +0.7% | 8,000 |
| 2013/06/17 | 1,331 | 1,377 | 1,330 | 1,377 | +46 | +3.5% | 16,000 |
| 2013/06/14 | 1,303 | 1,370 | 1,303 | 1,331 | +11 | +0.8% | 86,000 |
| 2013/06/13 | 1,349 | 1,349 | 1,309 | 1,320 | -32 | -2.4% | 24,000 |
2751～
2800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
